Linlin Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Linlin Wang has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Obtin Alkhamis
North Carolina State University 2620 Yarbrough Drive
5 shared publications- Yi Xiao
Department of Chemistry, North Carolina State University, 2620 Yarbrough Drive, Raleigh, North Carolina 27607, United States
5 shared publications Juan Canoura
Department of Chemistry, North Carolina State University, 2620 Yarbrough Dr., Raleigh, North Carolina 27695, United States
4 shared publicationsCaleb Byrd
Department of Chemistry, North Carolina State University, 2620 Yarbrough Drive, Raleigh, NC, 27607, USA
3 shared publicationsAlexandra Bryant
Department of Chemistry, North Carolina State University, 2620 Yarbrough Drive, Raleigh, NC, 27607, USA
2 shared publicationsAng Chang
Beijing National Laboratory for Molecular Sciences
1 shared publication
Latest Publications
- Open Access
- 24 July 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (30) , 22462-22472
A Selective, Class-Specific Aptamer for Fentanyl Analog Screening
Fentanyl and its analogs pose considerable dangers to public health and safety, and the development of simple tests that can detect these harmful substances accurately and rapidly could control their currently unchecked spread and thereby safeguard lives. Here, we use systematic evolution of ligands by exponential enrichment (SELEX) to isolate an aptamer that displays a rare blend of high affinity and broad cross-reactivity to 139 fentanyl analogs, alongside excellent specificity against nontarget interferents, including cutting agents, adulterants, and other drugs of abuse. We demonstrate the utility of this aptamer by developing a single-step colorimetric dye-displacement assay that can detect diverse fentanyl analogs within seconds with a simple mix-and-read format. The analog coverage of our assay rivals that of commercial immunoassay-based fentanyl tests while offering better specificity against substances that commonly trigger false positives in those tests, such as diphenhydramine, lidocaine, and methamphetamine. Our findings indicate that aptamers may be fundamentally better suited for achieving broad but specific detection of structurally related classes of molecules relative to other commonly used receptors, such as antibodies, due to their excellent and controllable binding properties, among other benefits, including low cost and high stability.
- 24 July 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (30) , 22462-22472
Open AccessA Selective, Class-Specific Aptamer for Fentanyl Analog Screening
Fentanyl and its analogs pose considerable dangers to public health and safety, and the development of simple tests that can detect these harmful substances accurately and rapidly could control their currently unchecked spread and thereby safeguard lives. Here, we use systematic evolution of ligands by exponential enrichment (SELEX) to isolate an aptamer that displays a rare blend of high affinity and broad cross-reactivity to 139 fentanyl analogs, alongside excellent specificity against nontarget interferents, including cutting agents, adulterants, and other drugs of abuse. We demonstrate the utility of this aptamer by developing a single-step colorimetric dye-displacement assay that can detect diverse fentanyl analogs within seconds with a simple mix-and-read format. The analog coverage of our assay rivals that of commercial immunoassay-based fentanyl tests while offering better specificity against substances that commonly trigger false positives in those tests, such as diphenhydramine, lidocaine, and methamphetamine. Our findings indicate that aptamers may be fundamentally better suited for achieving broad but specific detection of structurally related classes of molecules relative to other commonly used receptors, such as antibodies, due to their excellent and controllable binding properties, among other benefits, including low cost and high stability.
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
Development of electrochemical aptamer-based sensors for therapeutic monitoring of lamotrigine
Electrochemical aptamer-based sensors enable the quantification of the anti-epileptic drug lamotrigine directly in unprocessed blood, opening avenues towards convenient therapeutic drug monitoring at the point-of-care.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
Open AccessDevelopment of electrochemical aptamer-based sensors for therapeutic monitoring of lamotrigine
Electrochemical aptamer-based sensors enable the quantification of the anti-epileptic drug lamotrigine directly in unprocessed blood, opening avenues towards convenient therapeutic drug monitoring at the point-of-care.
- Open Access
- 11 November 2024
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 10 (12) , 2213-2228
Examining the Relationship between Aptamer Complexity and Molecular Discrimination of a Low-Epitope Target
Aptamers are oligonucleotide-based affinity reagents that are increasingly being used in various applications. Systematic evolution of ligands by exponential enrichment (SELEX) has been widely used to isolate aptamers for small-molecule targets, but it remains challenging to generate aptamers with high affinity and specificity for targets with few functional groups. To address this challenge, we have systematically evaluated strategies for optimizing the isolation of aptamers for (+)-methamphetamine, a target for which previously reported aptamers have weak or no binding affinity. We perform four trials of library-immobilized SELEX against (+)-methamphetamine and demonstrate that N30 libraries do not yield high-quality aptamers. However, by using a more complex N40 library design, stringent counter-SELEX, and fine-tuned selection conditions, we identify aptamers with high affinity for (+)-methamphetamine and better selectivity relative to existing antibodies. Bioinformatic analysis from our selections reveals that high-quality aptamers contain long conserved motifs and are more informationally dense. Finally, we demonstrate that our best aptamer can rapidly detect (+)-methamphetamine at toxicologically relevant concentrations in saliva in a colorimetric dye-displacement assay. The insights provided here demonstrate the challenges in generating high-quality aptamers for low complexity small-molecule targets and will help guide the design of more efficient future selection efforts.
- 11 November 2024
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 10 (12) , 2213-2228
Open AccessExamining the Relationship between Aptamer Complexity and Molecular Discrimination of a Low-Epitope Target
Aptamers are oligonucleotide-based affinity reagents that are increasingly being used in various applications. Systematic evolution of ligands by exponential enrichment (SELEX) has been widely used to isolate aptamers for small-molecule targets, but it remains challenging to generate aptamers with high affinity and specificity for targets with few functional groups. To address this challenge, we have systematically evaluated strategies for optimizing the isolation of aptamers for (+)-methamphetamine, a target for which previously reported aptamers have weak or no binding affinity. We perform four trials of library-immobilized SELEX against (+)-methamphetamine and demonstrate that N30 libraries do not yield high-quality aptamers. However, by using a more complex N40 library design, stringent counter-SELEX, and fine-tuned selection conditions, we identify aptamers with high affinity for (+)-methamphetamine and better selectivity relative to existing antibodies. Bioinformatic analysis from our selections reveals that high-quality aptamers contain long conserved motifs and are more informationally dense. Finally, we demonstrate that our best aptamer can rapidly detect (+)-methamphetamine at toxicologically relevant concentrations in saliva in a colorimetric dye-displacement assay. The insights provided here demonstrate the challenges in generating high-quality aptamers for low complexity small-molecule targets and will help guide the design of more efficient future selection efforts.
- 25 October 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (44) , 17720-17729
Determining the Precision of High-Throughput Sequencing and Its Influence on Aptamer Selection
In vitro selection offers a means of discovering functional nucleic acids from randomized libraries, and high-throughput sequencing (HTS) is a powerful tool for monitoring the evolution of oligonucleotide pools over many cycles of enrichment. Many groups now use HTS-derived measures of sequence enrichment across different rounds of in vitro selection to identify promising candidate sequences. However, the precision of HTS in this context─and its impact on the success or failure of the resulting aptamer selection process─remain poorly understood. Here, we conduct multiple independent Illumina-based sequencing trials of in vitro selected pools and empirically determine the precision of the resulting sequence abundance measurements. We find that measurements for sequences with abundance ≥0.1% are generally reliable, with relative standard deviations of in vitro selection. Our findings show that the utility of enrichment-based metrics is strongly dependent on the precision of the HTS data used to derive those metrics. These insights will prove beneficial for practitioners using HTS in isolating and characterizing functional oligonucleotides.
- 25 October 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (44) , 17720-17729
Determining the Precision of High-Throughput Sequencing and Its Influence on Aptamer Selection
In vitro selection offers a means of discovering functional nucleic acids from randomized libraries, and high-throughput sequencing (HTS) is a powerful tool for monitoring the evolution of oligonucleotide pools over many cycles of enrichment. Many groups now use HTS-derived measures of sequence enrichment across different rounds of in vitro selection to identify promising candidate sequences. However, the precision of HTS in this context─and its impact on the success or failure of the resulting aptamer selection process─remain poorly understood. Here, we conduct multiple independent Illumina-based sequencing trials of in vitro selected pools and empirically determine the precision of the resulting sequence abundance measurements. We find that measurements for sequences with abundance ≥0.1% are generally reliable, with relative standard deviations of in vitro selection. Our findings show that the utility of enrichment-based metrics is strongly dependent on the precision of the HTS data used to derive those metrics. These insights will prove beneficial for practitioners using HTS in isolating and characterizing functional oligonucleotides.
- 23 July 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (31) , 21296-21307
Rapid Nuclease-Assisted Selection of High-Affinity Small-Molecule Aptamers
Aptamers are nucleic acid bioreceptors that have been widely utilized for a variety of biosensing applications, including in vivo detection methods that would not be possible with antibody-based systems. However, it remains challenging to generate high-quality aptamers for small molecule targets, particularly for use under physiological conditions. We present a highly effective aptamer selection technology for small-molecule targets that utilizes the nuclease EcoRI to remove nonspecific or weakly binding sequences in solution phase, rapidly enriching high-affinity target binders within just a few rounds of selection. As proof-of-concept, we used our nuclease-assisted SELEX (NA-SELEX) method to isolate aptamers for a synthetic cannabinoid, AB-FUBINACA. Within five rounds, we identified two highly specific aptamers that exhibit nanomolar affinity at physiological temperature. We also demonstrate the robustness and reproducibility of NA-SELEX by performing the same selection experiment with fresh reagents and libraries, obtaining the same two aptamers as well as two other high-quality aptamer candidates. Finally, we compare NA-SELEX against a conventional library-immobilized SELEX screen for AB-FUBINACA using the same screening conditions, identifying aptamers with 25-100-fold weaker affinity after 11 rounds of selection. NA-SELEX therefore could be an effective selection method for the isolation of high-quality aptamers for small-molecule targets.
- 23 July 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (31) , 21296-21307
Rapid Nuclease-Assisted Selection of High-Affinity Small-Molecule Aptamers
Aptamers are nucleic acid bioreceptors that have been widely utilized for a variety of biosensing applications, including in vivo detection methods that would not be possible with antibody-based systems. However, it remains challenging to generate high-quality aptamers for small molecule targets, particularly for use under physiological conditions. We present a highly effective aptamer selection technology for small-molecule targets that utilizes the nuclease EcoRI to remove nonspecific or weakly binding sequences in solution phase, rapidly enriching high-affinity target binders within just a few rounds of selection. As proof-of-concept, we used our nuclease-assisted SELEX (NA-SELEX) method to isolate aptamers for a synthetic cannabinoid, AB-FUBINACA. Within five rounds, we identified two highly specific aptamers that exhibit nanomolar affinity at physiological temperature. We also demonstrate the robustness and reproducibility of NA-SELEX by performing the same selection experiment with fresh reagents and libraries, obtaining the same two aptamers as well as two other high-quality aptamer candidates. Finally, we compare NA-SELEX against a conventional library-immobilized SELEX screen for AB-FUBINACA using the same screening conditions, identifying aptamers with 25-100-fold weaker affinity after 11 rounds of selection. NA-SELEX therefore could be an effective selection method for the isolation of high-quality aptamers for small-molecule targets.
- 22 May 2023
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 145 (22) , 12407-12422
Comparison of Aptamer Signaling Mechanisms Reveals Disparities in Sensor Response and Strategies to Eliminate False Signals
Aptamers are nucleic acid-based affinity reagents that have been incorporated into a variety of molecular sensor formats. However, many aptamer sensors exhibit insufficient sensitivity and specificity for real-world applications, and although considerable effort has been dedicated to improving sensitivity, sensor specificity has remained largely neglected and understudied. In this work, we have developed a series of sensors using aptamers for the small-molecule drugs flunixin, fentanyl, and furanyl fentanyl and compare their performance─in particular, focusing on their specificity. Contrary to expectations, we observe that sensors using the same aptamer operating under the same physicochemical conditions produce divergent responses to interferents depending on their signal transduction mechanism. For instance, aptamer beacon sensors are susceptible to false-positives from interferents that weakly associate with DNA, while strand-displacement sensors suffer from false-negatives due to interferent-associated signal suppression when both the target and interferent are present. Biophysical analyses suggest that these effects arise from aptamer-interferent interactions that are either nonspecific or induce aptamer conformational changes that are distinct from those induced by true target-binding events. We also demonstrate strategies for improving the sensitivity and specificity of aptamer sensors with the development of a "hybrid beacon," wherein the incorporation of a complementary DNA competitor into an aptamer beacon selectively hinders interferent─but not target─binding and signaling, while simultaneously overcoming signal suppression by interferents. Our results highlight the need for systematic and thorough testing of aptamer sensor response and new aptamer selection methods that optimize specificity more effectively than traditional counter-SELEX.
- 22 May 2023
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 145 (22) , 12407-12422
Comparison of Aptamer Signaling Mechanisms Reveals Disparities in Sensor Response and Strategies to Eliminate False Signals
Aptamers are nucleic acid-based affinity reagents that have been incorporated into a variety of molecular sensor formats. However, many aptamer sensors exhibit insufficient sensitivity and specificity for real-world applications, and although considerable effort has been dedicated to improving sensitivity, sensor specificity has remained largely neglected and understudied. In this work, we have developed a series of sensors using aptamers for the small-molecule drugs flunixin, fentanyl, and furanyl fentanyl and compare their performance─in particular, focusing on their specificity. Contrary to expectations, we observe that sensors using the same aptamer operating under the same physicochemical conditions produce divergent responses to interferents depending on their signal transduction mechanism. For instance, aptamer beacon sensors are susceptible to false-positives from interferents that weakly associate with DNA, while strand-displacement sensors suffer from false-negatives due to interferent-associated signal suppression when both the target and interferent are present. Biophysical analyses suggest that these effects arise from aptamer-interferent interactions that are either nonspecific or induce aptamer conformational changes that are distinct from those induced by true target-binding events. We also demonstrate strategies for improving the sensitivity and specificity of aptamer sensors with the development of a "hybrid beacon," wherein the incorporation of a complementary DNA competitor into an aptamer beacon selectively hinders interferent─but not target─binding and signaling, while simultaneously overcoming signal suppression by interferents. Our results highlight the need for systematic and thorough testing of aptamer sensor response and new aptamer selection methods that optimize specificity more effectively than traditional counter-SELEX.
- 16 December 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 62 (4) , e202214169
Engineering Hierarchical Recognition‐Mediated Senolytics for Reliable Regulation of Cellular Senescence and Anti‐Atherosclerosis Therapy
Precise regulation of vascular senescence represents a far‐reaching strategy to combat age‐related diseases. However, the high heterogeneity of senescence, alongside the lack of targeting and potent senolytics, makes it very challenging. Here we report a molecular design to tackle this challenge through multidimensional, hierarchical recognition of three hallmarks commonly shared among senescence, namely, aptamer‐mediated recognition of a membrane marker for active cell targeting, a self‐immolative linker responsive to lysosomal enzymes for switchable drug release, and a compound against antiapoptotic signaling for clearance. Such senolytic can target and trigger severe cell apoptosis in broad‐spectrum senescent endothelial cells, and importantly, distinguish them from the quiescent state. Its potential for in vivo treatment of vascular diseases is successfully illustrated in a model of atherosclerosis, with effective suppression of the plaque progression yet negligible side effects.
- 16 December 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 62 (4) , e202214169
Engineering Hierarchical Recognition‐Mediated Senolytics for Reliable Regulation of Cellular Senescence and Anti‐Atherosclerosis Therapy
Precise regulation of vascular senescence represents a far‐reaching strategy to combat age‐related diseases. However, the high heterogeneity of senescence, alongside the lack of targeting and potent senolytics, makes it very challenging. Here we report a molecular design to tackle this challenge through multidimensional, hierarchical recognition of three hallmarks commonly shared among senescence, namely, aptamer‐mediated recognition of a membrane marker for active cell targeting, a self‐immolative linker responsive to lysosomal enzymes for switchable drug release, and a compound against antiapoptotic signaling for clearance. Such senolytic can target and trigger severe cell apoptosis in broad‐spectrum senescent endothelial cells, and importantly, distinguish them from the quiescent state. Its potential for in vivo treatment of vascular diseases is successfully illustrated in a model of atherosclerosis, with effective suppression of the plaque progression yet negligible side effects.
- 16 September 2014
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 12 (45) , 9207-9215
Effects of side chains on DNA binding, cell permeability, nuclear localization and cytotoxicity of 4-aminonaphthalimides
Nucleic acid binding molecules have been extensively explored for nucleic acid assay, nuclear imaging, and antitumor and antivirus therapies. Most of these molecules usually bear positive charges to enhance their binding affinity. However, their in vivo applications are limited by poor membrane permeability and the lack of selectivity to nucleic acids. Here we describe the effects of positive charged side chains (including aminoethyl, dimethylaminopropyl and guanidinoethyl) on the DNA binding ability, cell permeability, cellular localization and cytotoxicity of 4-aminonaphthalimides, a class of DNA-intercalating agents and fluorophores. The synthesized 4-aminonaphthalimides have a strong binding ability to duplex DNA, and can be used as pre-staining dyes for gel electrophoresis of DNA and RNA. When entering into cells, they rapidly concentrate in cell nuclei, especially in nucleoli. The guanidinoethyl side chains increase the binding ability to nucleic acids, but do not favour the cell permeability and cytotoxicity; dimethylaminopropyl groups enhance the cell permeability and cytotoxicity of 4-aminonaphthalimides. These results suggest the potential applications of 4-aminonaphthalimides in nucleic acid assay and nuclear imaging, and provide useful information for the molecular design of DNA-binding drugs and fluorescent probes.
- 16 September 2014
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 12 (45) , 9207-9215
Effects of side chains on DNA binding, cell permeability, nuclear localization and cytotoxicity of 4-aminonaphthalimides
Nucleic acid binding molecules have been extensively explored for nucleic acid assay, nuclear imaging, and antitumor and antivirus therapies. Most of these molecules usually bear positive charges to enhance their binding affinity. However, their in vivo applications are limited by poor membrane permeability and the lack of selectivity to nucleic acids. Here we describe the effects of positive charged side chains (including aminoethyl, dimethylaminopropyl and guanidinoethyl) on the DNA binding ability, cell permeability, cellular localization and cytotoxicity of 4-aminonaphthalimides, a class of DNA-intercalating agents and fluorophores. The synthesized 4-aminonaphthalimides have a strong binding ability to duplex DNA, and can be used as pre-staining dyes for gel electrophoresis of DNA and RNA. When entering into cells, they rapidly concentrate in cell nuclei, especially in nucleoli. The guanidinoethyl side chains increase the binding ability to nucleic acids, but do not favour the cell permeability and cytotoxicity; dimethylaminopropyl groups enhance the cell permeability and cytotoxicity of 4-aminonaphthalimides. These results suggest the potential applications of 4-aminonaphthalimides in nucleic acid assay and nuclear imaging, and provide useful information for the molecular design of DNA-binding drugs and fluorescent probes.